# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Bladder cancer

SCCBSmall cell bladder cancerSmall cell bladder carcinoma; Small cell carcinoma of the urinary bladderBladder carcinomaSmall cell carninoma of the bladderPoorly differentiated neuroendocrine carcinoma of the bladder;
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 347 results.
Rogaratinib for BCG Refractory High Risk Non-Muscle Invasive Bladder Cancer With FGFR1/2 Overexpression
Status: Not yet recruiting
Last Changed: Aug 02, 2019
First Received: Aug 01, 2019
Disease(s): Bladder Cancer
Intervention(s): Rogaratinib
Locations: Dana Farber Cancer Institute, Boston, Massachusetts, United States
Multidisciplinary Bladder-preservation Therapy for Bladder Cancer
Status: Recruiting
Last Changed: Nov 28, 2018
First Received: Nov 28, 2018
Disease(s): Bladder Cancer
Intervention(s): multidisciplinary bladder-preservation therapy
Locations: Peking University Third Hospital, Beijing, Beijing, China
Paclitaxel-binding Albumin and Cisplatin as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer
Status: Recruiting
Last Changed: Aug 19, 2019
First Received: Aug 19, 2019
Disease(s): Bladder Cancer
Intervention(s): Paclitaxel-binding albumin
Locations: Daping Hospital, Third Military Medical University, Chongqing, Chongqing, China
Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer
Status: Recruiting
Last Changed: Jul 03, 2019
First Received: Jan 25, 2016
Disease(s): Bladder Cancer
Intervention(s): Pembrolizumab, Cisplatin, Radiotherapy
Locations: Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia
Liverpool Hospital, Liverpool, New South Wales, Australia
Prince of Wales Hospital, Randwick, New South Wales, Australia
Royal North Shore Hospital, St Leonards, New South Wales, Australia
Austin Health, Heidelberg, Victoria, Australia
... and 3 other locations.
Treatment of High-risk Non-muscle Invasive Bladder Cancer With IMUNO BGC Moreau RJ as Prophylaxis
Status: Recruiting
Last Changed: Jun 12, 2019
First Received: Jun 12, 2019
Disease(s): Bladder Cancer
Intervention(s): Instillation of IMUNO BCG Moreau RJ
Locations: Hospital Universitario Basurto, Bilbao, Spain
Complejo Hospitalario Puerta Del Mar, Cadiz, Spain
Complexo Hospitalario Universitario A Coruña, Coruña, Spain
Complejo Hospitalario Regional Reina Sofía, Córdoba, Spain
Hospital Universitario Virgen de Las Nieves, Granada, Spain
... and 11 other locations.
Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer
Status: Recruiting
Last Changed: Aug 16, 2018
First Received: Sep 01, 2016
Disease(s): Bladder Cancer
Intervention(s): Celecoxib, Gemcitabine, Cisplatin
Locations: Baylor Clinic, Houston, Texas, United States
Harris Health System - Smith Clinic, Houston, Texas, United States
Xpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation Study
Status: Recruiting
Last Changed: Sep 12, 2019
First Received: Oct 23, 2018
Disease(s): Bladder Cancer
Intervention(s): Xpert bladder cancer monitor
Locations: Urology and Nephrology Center, Mansourah, Egypt
A Feasibility Study of Durvalumab +/- Oleclumab as Neoadjuvant Therapy for Muscle-invasive Bladder Cancer (BLASST-2)
Status: Recruiting
Last Changed: Feb 26, 2019
First Received: Dec 12, 2018
Disease(s): Muscle Invasive Bladder Cancer
Intervention(s): Durvalumab, Oleclumab
Locations: Massachusetts General Hospital, Boston, Massachusetts, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
The Difference of Two Year Recurrence Rate According to Anesthetic Method During Transurethral Resection of Bladder Mass in Patients With Non-muscle Invasive Bladder Cancer: Prospective, Randomized, Clinical Phase II Study
Status: Not yet recruiting
Last Changed: Jul 24, 2018
First Received: Jul 24, 2018
Disease(s): Bladder Cancer
Intervention(s): Anesthesia before transurethral resection of the bladder tumor, Anesthesia
Locations: Seoul National University Hospital, Seoul, Korea, Republic of
Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer
Status: Recruiting
Last Changed: Jul 19, 2019
First Received: Jun 07, 2019
Disease(s): Bladder Cancer
Intervention(s): Pembrolizumab, Entinostat
Locations: Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States